Literature DB >> 23266626

FMO3 allelic variants in Sicilian and Sardinian populations: trimethylaminuria and absence of fish-like body odor.

Rosalia D'Angelo1, Teresa Esposito, Marco Calabrò, Carmela Rinaldi, Renato Robledo, Bruno Varriale, Antonina Sidoti.   

Abstract

The N-oxygenation of amines by the human flavin-containing monooxygenase (form 3) (FMO3) represents an important means for the conversion of lipophilic nucleophilic heteroatom-containing compounds into more polar and readily excreted products. In healthy individuals, virtually all Trimethylamine (TMA) are metabolized to Trimethylamine N-oxide (TMAO). Several single nucleotide polymorphisms (SNPs) of the FMO3 gene have been described and result in an enzyme with decreased or abolished functional activity for TMA N-oxygenation thus leading to TMAU, or fish-like odor syndrome. Three coding region variants, c. G472A (p.E158K) in exon 4, c. G769A (p.V257M) in exon 6, and c.A923G (p.E308G) in exon 7, are common polymorphisms identified in all population examined so far and are associated with normal or slightly reduced TMA N-oxygenation activity. However, simultaneous occurrence of 158K and 308G variants results in a more pronounced decrease in FMO3 activity. A fourth polymorphism, c. G1424A (p.G475D) in exon 9, less common in the general population, was observed in individuals suffering severe or moderate trimethylaminuria. The aim of this study was to determine the allelic and genotypic distributions of these four FMO3 variants in 528 healthy individuals collected from the Sicilian and Sardinian populations together with haplotype and linkage analyses. Finally, we present data on the genotype-phenotype correlation by ESI-MS/MS TMA/TMAO urinary determination in 158KK/308EG individuals. Variant 158K shows the same frequency in Sicilian and Sardinian populations while variant 257M was not observed in the Sardinian sampling. No significant differences were found for 308G and 475D variants among two populations. Cis-linkage between 158K and 308G was confirmed with the compound variant (158K-308G) being found in a proportion of 0.9% and 0.3% of Sicilian subjects, and 0.01% and 0.5% in Sardinian population. Urinary determination of TMA/TMAO ratio in 158KK/308EG individuals showed a considerable reduction in FMO3 activity although they do not show the classical features of trimethylaminuria as a strong body odor and breath. Our data support the conclusion that trimethylaminuria is not always accompanied by a fish-like odor, despite the coexistence in the same individual of the two variants 158K and 308G, and other factors account for the expression of that phenotype.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23266626     DOI: 10.1016/j.gene.2012.12.047

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  9 in total

Review 1.  Unraveling the environmental and genetic interactions in atherosclerosis: Central role of the gut microbiota.

Authors:  Elin Org; Margarete Mehrabian; Aldons J Lusis
Journal:  Atherosclerosis       Date:  2015-06-03       Impact factor: 5.162

Review 2.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

3.  Association of FMO3 rs1736557 polymorphism with clopidogrel response in Chinese patients with coronary artery disease.

Authors:  Kong-Xiang Zhu; Pei-Yuan Song; Mu-Peng Li; Yin-Xiao Du; Qi-Lin Ma; Li-Ming Peng; Xiao-Ping Chen
Journal:  Eur J Clin Pharmacol       Date:  2020-10-21       Impact factor: 2.953

4.  Archaebiotics: proposed therapeutic use of archaea to prevent trimethylaminuria and cardiovascular disease.

Authors:  Jean-François Brugère; Guillaume Borrel; Nadia Gaci; William Tottey; Paul W O'Toole; Corinne Malpuech-Brugère
Journal:  Gut Microbes       Date:  2013-10-31

5.  The genetic and biochemical basis of trimethylaminuria in an Irish cohort.

Authors:  Samantha Doyle; James J O'Byrne; Mandy Nesbitt; Daniel N Murphy; Zaza Abidin; Niall Byrne; Gregory Pastores; Richard Kirk; Eileen P Treacy
Journal:  JIMD Rep       Date:  2019-03-25

6.  Adaptive Modelling of Mutated FMO3 Enzyme Could Unveil Unexplored Scenarios Linking Variant Haplotypes to TMAU Phenotypes.

Authors:  Simona Alibrandi; Fabiana Nicita; Luigi Donato; Concetta Scimone; Carmela Rinaldi; Rosalia D'Angelo; Antonina Sidoti
Journal:  Molecules       Date:  2021-11-22       Impact factor: 4.411

Review 7.  The Accumulation and Molecular Effects of Trimethylamine N-Oxide on Metabolic Tissues: It's Not All Bad.

Authors:  Emily S Krueger; Trevor S Lloyd; Jeffery S Tessem
Journal:  Nutrients       Date:  2021-08-21       Impact factor: 5.717

Review 8.  TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review.

Authors:  Ye Zixin; Chen Lulu; Zeng Xiangchang; Fang Qing; Zheng Binjie; Luo Chunyang; Rao Tai; Ouyang Dongsheng
Journal:  Front Pharmacol       Date:  2022-08-12       Impact factor: 5.988

9.  Fish odor syndrome (trimethylaminuria) supporting the possible FMO3 down expression in childhood: a case report.

Authors:  Rosalia D'Angelo; Concetta Scimone; Teresa Esposito; Daniele Bruschetta; Carmela Rinaldi; Alessia Ruggeri; Antonina Sidoti
Journal:  J Med Case Rep       Date:  2014-10-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.